21 – 30 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
- Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients : a double-blinded randomized controlled trial (
- 2012
- Influence of genetics in the expression of serological markers in twins with IBD (
- Pilot study on the safety and efficacy of faecal microbiota transplantation in refractory Crohn's disease (
- Bacterial dysbiosis in ulcerative colitis patients differs from Crohn's disease patients (
- Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (
- Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease : results from a double-blinded randomised controlled trial (
- Factors determining therapeutic strategy at diagnosis and evolution of disease severity in a cohort of Belgian pediatric Crohn's disease patients (BELCRO) (
- Assessment of the microbiota in microdissected tissues of Crohn's disease patients (
- Management of inflammatory bowel disease in pregnancy (
- 2011
- Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (